Biology and clinical implications of CD133(+) liver cancer stem cells.

Experimental cell research , Vol. 319, No. 2. , pp. 126-132, doi:10.1016/j.yexcr.2012.09.007 Hepatocellular carcinoma is the most common primary malignant tumor of the liver, accounting for 80%-90% of all liver cancers.

http://www.citeulike.org/user/guhjy/article/12791324